A fluoro analogue of the menadione deriva-NOVEL TARGETS FOR ANTIMALARIAL CHEMOTHERAPY ,
, -methyl)-1',4'-naphthoquinolyl]hexanoic acid is a suicide substrate of glutathione reductase. Crystal structure of the alkylated human enzyme, J. Am. Chem. Soc, vol.128, pp.10784-10794, 2006.
,
Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob. Agents Chemother, vol.51, pp.1463-1472, 2007. ,
Protein farnesyltransferase and protein prenylation in Plasmodium falciparum, J. Biol. Chem, vol.277, pp.42066-42073, 2002. ,
Antimalarial drug discovery: targeting protein kinases, Expert. Opin. Ther. Targets, vol.11, pp.279-290, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00169407
Resistance to a protein farnesyltransferase inhibitor in Plasmodium falciparum, J. Biol. Chem, vol.280, pp.13554-13559, 2005. ,
Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase, Mol. Biochem. Parasitol, vol.152, pp.66-71, 2007. ,
Artemisinins target the SERCA of Plasmodium falciparum, Nature, vol.424, pp.957-961, 2003. ,
Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents, J. Med. Chem, vol.50, pp.1322-1334, 2007. ,
Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum, Science, vol.299, pp.705-708, 2003. ,
X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy, J. Biol. Chem, vol.282, pp.25436-25444, 2007. ,
Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics, Mol. Biochem. Parasitol, vol.126, pp.155-163, 2003. ,
Hemoglobin degradation, Curr. Top. Microbiol. Immunol, vol.295, pp.275-291, 2005. ,
Current perspectives on the mechanism of action of artemisinins, Int. J. Parasitol, vol.36, pp.1427-1441, 2006. ,
The effects of antibacterials on the malaria parasite Plasmodium falciparum, Mol. Biochem. Parasitol, vol.152, pp.181-191, 2007. ,
Targeting purine and pyrimidine metabolism in human apicomplexan parasites, Curr. Drug Targets, vol.8, pp.31-47, 2007. ,
, Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6, vol.366, pp.1960-1963, 2005.
Three-dimensional structure of Plasmodium falciparum Ca 2+ -ATPase(PfATP6) and docking of artemisinin derivatives to PfATP6, Bioorg. Med. Chem. Lett, vol.15, pp.2994-2997, 2005. ,
Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance, Trends Mol. Med, vol.12, pp.200-205, 2006. ,
Anti-Plasmodium activity of ceramide analogs, Malar. J, p.49, 2004. ,
URL : https://hal.archives-ouvertes.fr/mnhn-02070122
Clindamycin as an antimalarial drug: review of clinical trials, Antimicrob. Agents Chemother, vol.46, pp.2315-2320, 2002. ,
Fosmidomycin, a novel chemotherapeutic agent for malaria, Antimicrob. Agents Chemother, vol.47, pp.735-738, 2003. ,
Antimalarial compounds from traditionally-used medicinal plants, in: Bioactive natural products. Detection, isolation and structural determination, pp.491-529, 2007. ,
Mitochondrial drug targets in apicomplexan parasites, Curr. Drug Targets, vol.8, pp.49-60, 2007. ,
Make it or take it: fatty acid metabolism of apicomplexan parasites, Eukaryot. Cell, vol.6, pp.1727-1735, 2007. ,
Plasmodium falciparum: interaction of shikimate analogues with antimalarial drugs, Exp. Parasitol, vol.111, pp.178-181, 2005. ,
Association of failures of seven-day courses of artesunate in a nonimmune population in Bangui, Central African Republic with decreased sensitivity of Plasmodium falciparum, Am J. Trop. Med. Hyg, vol.73, pp.616-621, 2005. ,
Comparative genomic and phylogenetic analyses of calcium ATPases and calcium-regulated proteins in the apicomplexa, Mol. Biol. Evol, vol.23, pp.1613-1627, 2006. ,
Protein farnesyltransferase inhibitors exhibit potent antimalarial activity, J. Med. Chem, vol.48, pp.3704-3713, 2005. ,
The role of malaria merozoite proteases in red blood cell invasion, Curr. Opin. Microbiol, vol.8, pp.422-427, 2005. ,
Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity, Bioorg. Med. Chem. Lett, vol.11, pp.761-764, 2001. ,
A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs, Curr. Top. Med. Chem, vol.6, pp.479-507, 2006. ,
Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria, Antimicrob. Agents Chemother, vol.51, pp.1869-1871, 2007. ,
An alternative model for heme biosynthesis in the malarial parasite, Trends Biochem. Sci, vol.32, pp.443-449, 2007. ,
Towards systematic identification of Plasmodium essential genes by transposon shuttle mutagenesis, Nucleic Acids Res, p.174, 2005. ,
Enzymes for heme biosynthesis are found in both the mitochondrion and plastid of the malaria parasite Plasmodium falciparum, Protist, vol.155, pp.117-125, 2004. ,
The plastid of Plasmodium spp.: a target for inhibitors, Curr. Top. Microbiol. Immunol, vol.295, pp.251-273, 2005. ,
,
Methylene blue as an antimalarial agent, Redox Rep, vol.8, pp.272-275, 2003. ,
Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) enzyme, Curr. Pharm. Des, vol.13, pp.1161-1177, 2007. ,
de novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite, Biochem. Biophys. Res. Commun, vol.187, pp.744-750, 1992. ,
Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum, Nat. Med, vol.7, pp.167-173, 2001. ,
A single amino acid residue can determine the sensitivity of SERCAs to artemisinins, Nat. Struct. Mol. Biol, vol.12, pp.628-629, 2005. ,
, Pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase, vol.51, pp.3659-3671, 2007.
, NOVEL TARGETS FOR ANTIMALARIAL CHEMOTHERAPY, vol.225
, , 2008.
, Parasite, vol.15, pp.219-225, 2008.
,
Identification of an antimalarial synthetic trioxolane drug development candidate, Nature, vol.430, pp.900-904, 2004. ,
Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum, Proc. Natl. Acad. Sci. USA, vol.95, pp.12352-12357, 1998. ,
A class of potent antimalarials and their specific accumulation in infected erythrocytes, Science, vol.295, pp.1311-1314, 2002. ,
Isoprenoid biosynthesis of the apicoplast as drug target, Curr. Drug Targets, vol.8, pp.3-13, 2007. ,
Farnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivo, Angew. Chem. Int. Ed. Engl, vol.43, pp.251-254, 2004. ,
Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance, Cell. Mol. Life Sci, vol.63, pp.1586-1596, 2006. ,